Opioids Drugs Market Report

Global and Regional Opioids Drugs Market Details Research Report 2021-2026

  • POSTDATE：Jun 27, 2021
  • PAGES：208
  • REPORT CODE：GMM737530
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Opioids Drugs Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Opioids Drugs market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Opioids Drugs market.

    By Player:

    • Purdue Pharma

    • Teva

    • Depomed

    • Vistapharm

    • J&J

    • INSYS

    • Pernix

    • Pfizer

    • Egalet

    • Hikma

    • Endo

    • Mylan

    • Mallinckrodt

    By Type:

    • Oxycodone

    • Hydromorphone

    • Codeine

    • Fentanyl

    • Other

    By End-User:

    • Pain Relief

    • Anesthesia

    • Other

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Opioids Drugs Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Opioids Drugs Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Opioids Drugs Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Opioids Drugs Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Opioids Drugs Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Opioids Drugs Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Purdue Pharma

      • 3.1.1 Purdue Pharma - Company Business Overview

      • 3.1.2 Purdue Pharma - Company Financial Performance

      • 3.1.3 Purdue Pharma - Company Financial Performance of Opioids Drugs

      • 3.1.4 Opioids Drugs Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Teva

      • 3.2.1 Teva - Company Business Overview

      • 3.2.2 Teva - Company Financial Performance

      • 3.2.3 Teva - Company Financial Performance of Opioids Drugs

      • 3.2.4 Opioids Drugs Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Depomed

      • 3.3.1 Depomed - Company Business Overview

      • 3.3.2 Depomed - Company Financial Performance

      • 3.3.3 Depomed - Company Financial Performance of Opioids Drugs

      • 3.3.4 Opioids Drugs Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Vistapharm

      • 3.4.1 Vistapharm - Company Business Overview

      • 3.4.2 Vistapharm - Company Financial Performance

      • 3.4.3 Vistapharm - Company Financial Performance of Opioids Drugs

      • 3.4.4 Opioids Drugs Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 J&J

      • 3.5.1 J&J - Company Business Overview

      • 3.5.2 J&J - Company Financial Performance

      • 3.5.3 J&J - Company Financial Performance of Opioids Drugs

      • 3.5.4 Opioids Drugs Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 INSYS

      • 3.6.1 INSYS - Company Business Overview

      • 3.6.2 INSYS - Company Financial Performance

      • 3.6.3 INSYS - Company Financial Performance of Opioids Drugs

      • 3.6.4 Opioids Drugs Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Pernix

      • 3.7.1 Pernix - Company Business Overview

      • 3.7.2 Pernix - Company Financial Performance

      • 3.7.3 Pernix - Company Financial Performance of Opioids Drugs

      • 3.7.4 Opioids Drugs Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Pfizer

      • 3.8.1 Pfizer - Company Business Overview

      • 3.8.2 Pfizer - Company Financial Performance

      • 3.8.3 Pfizer - Company Financial Performance of Opioids Drugs

      • 3.8.4 Opioids Drugs Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Egalet

      • 3.9.1 Egalet - Company Business Overview

      • 3.9.2 Egalet - Company Financial Performance

      • 3.9.3 Egalet - Company Financial Performance of Opioids Drugs

      • 3.9.4 Opioids Drugs Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Hikma

      • 3.10.1 Hikma - Company Business Overview

      • 3.10.2 Hikma - Company Financial Performance

      • 3.10.3 Hikma - Company Financial Performance of Opioids Drugs

      • 3.10.4 Opioids Drugs Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Endo

      • 3.11.1 Endo - Company Business Overview

      • 3.11.2 Endo - Company Financial Performance

      • 3.11.3 Endo - Company Financial Performance of Opioids Drugs

      • 3.11.4 Opioids Drugs Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Mylan

      • 3.12.1 Mylan - Company Business Overview

      • 3.12.2 Mylan - Company Financial Performance

      • 3.12.3 Mylan - Company Financial Performance of Opioids Drugs

      • 3.12.4 Opioids Drugs Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Mallinckrodt

      • 3.13.1 Mallinckrodt - Company Business Overview

      • 3.13.2 Mallinckrodt - Company Financial Performance

      • 3.13.3 Mallinckrodt - Company Financial Performance of Opioids Drugs

      • 3.13.4 Opioids Drugs Product Benchmarking

      • 3.13.5 Strategic Initiatives

    4 Global Opioids Drugs Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Opioids Drugs Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Oxycodone 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Hydromorphone 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Codeine 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Fentanyl 2016-2021

      • 4.2.5 Global Revenue and Growth Rate of Other 2016-2021

    • 4.3 Global Opioids Drugs Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Oxycodone 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Hydromorphone 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Codeine 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Fentanyl 2016-2021

      • 4.3.5 Global Sales and Growth Rate of Other 2016-2021

    • 4.4 Global Opioids Drugs Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Opioids Drugs Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Opioids Drugs Market Price By Type from 2016 to 2026

    5 Global Opioids Drugs Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Opioids Drugs

    • 5.2 Global Opioids Drugs Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Pain Relief 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Anesthesia 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Other 2016-2021

    • 5.3 Global Opioids Drugs Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Pain Relief 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Anesthesia 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Other 2016-2021

    • 5.4 Global Opioids Drugs Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Opioids Drugs Market Sales and Market Share by Application (Forecast)

    6 Global Opioids Drugs Market Segment Analysis (Geography Level)

    • 6.1 Global Opioids Drugs Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Opioids Drugs Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Opioids Drugs Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Opioids Drugs Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Opioids Drugs Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Opioids Drugs Market from 2016 to 2020

    7. North America Opioids Drugs Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Opioids Drugs Market Segment by Countries

      • 7.1.1 North America Opioids Drugs Market Revenue Segment by Countries

      • 7.1.2 North America Opioids Drugs Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Opioids Drugs Market Segment (Product Type Level)

    • 7.3 North America Opioids Drugs Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Opioids Drugs Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Opioids Drugs Market Segment by Countries

      • 8.1.1 Europe Opioids Drugs Market Revenue Segment by Countries

      • 8.1.2 Europe Opioids Drugs Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Opioids Drugs Market Segment (Product Type Level)

    • 8.3 Europe Opioids Drugs Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Opioids Drugs Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Opioids Drugs Market Segment by Countries

      • 9.1.1 Asia Opioids Drugs Market Revenue Segment by Countries

      • 9.1.2 Asia Opioids Drugs Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Opioids Drugs Market Segment (Product Type Level)

    • 9.3 Asia Opioids Drugs Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Opioids Drugs Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Opioids Drugs Market Segment by Countries

      • 10.1.1 South America Opioids Drugs Market Revenue Segment by Countries

      • 10.1.2 South America Opioids Drugs Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Opioids Drugs Market Segment (Product Type Level)

    • 10.3 South America Opioids Drugs Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Opioids Drugs Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Opioids Drugs Market Segment by Countries

      • 11.1.1 Middle East Opioids Drugs Market Revenue Segment by Countries

      • 11.1.2 Middle East Opioids Drugs Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Opioids Drugs Market Segment (Product Type Level)

    • 11.3 Middle East Opioids Drugs Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Opioids Drugs Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Opioids Drugs Market Segment by Countries

      • 12.1.1 Africa Opioids Drugs Market Revenue Segment by Countries

      • 12.1.2 Africa Opioids Drugs Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Opioids Drugs Market Segment (Product Type Level)

    • 12.3 Africa Opioids Drugs Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Opioids Drugs Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Opioids Drugs Market Segment by Countries

      • 13.1.1 Oceania Opioids Drugs Market Revenue Segment by Countries

      • 13.1.2 Oceania Opioids Drugs Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Opioids Drugs Market Segment (Product Type Level)

    • 13.3 Oceania Opioids Drugs Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Opioids Drugs Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Opioids Drugs

      • 14.2.2 Manufacturing Process Analysis of Opioids Drugs

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Opioids Drugs Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Opioids Drugs Industry Market Status, Pre-COVID-19

      • 15.5.3 Opioids Drugs Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Opioids Drugs Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Opioids Drugs Product Picture

    • Table Opioids Drugs Product Definition

    • Table Study Scope by Types

    • Figure Global Opioids Drugs Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Opioids Drugs Market Value by Application (2016 - 2026)

    • Figure Global Opioids Drugs Market Size and Growth Rate from 2016 to 2026

    • Table Global Opioids Drugs Production Capacity by Manufacturers (2016-2021)

    • Table Global Opioids Drugs Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Opioids Drugs Revenue by Manufacturers (2016-2021)

    • Table Global Opioids Drugs Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Opioids Drugs Plant Distribution and Sales Country

    • Table Purdue Pharma - Company Business Overview

    • Figure Purdue Pharma Total Revenue from 2018 to 2020

    • Table Purdue Pharma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Purdue Pharma Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Opioids Drugs Product Benchmarking

    • Table Teva - Company Business Overview

    • Figure Teva Total Revenue from 2018 to 2020

    • Table Teva Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Teva Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Teva

    • Table Opioids Drugs Product Benchmarking

    • Table Depomed - Company Business Overview

    • Figure Depomed Total Revenue from 2018 to 2020

    • Table Depomed Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Depomed Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Depomed

    • Table Opioids Drugs Product Benchmarking

    • Table Vistapharm - Company Business Overview

    • Figure Vistapharm Total Revenue from 2018 to 2020

    • Table Vistapharm Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Vistapharm Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Vistapharm

    • Table Opioids Drugs Product Benchmarking

    • Table J&J - Company Business Overview

    • Figure J&J Total Revenue from 2018 to 2020

    • Table J&J Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure J&J Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of J&J

    • Table Opioids Drugs Product Benchmarking

    • Table INSYS - Company Business Overview

    • Figure INSYS Total Revenue from 2018 to 2020

    • Table INSYS Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure INSYS Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of INSYS

    • Table Opioids Drugs Product Benchmarking

    • Table Pernix - Company Business Overview

    • Figure Pernix Total Revenue from 2018 to 2020

    • Table Pernix Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pernix Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Pernix

    • Table Opioids Drugs Product Benchmarking

    • Table Pfizer - Company Business Overview

    • Figure Pfizer Total Revenue from 2018 to 2020

    • Table Pfizer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pfizer Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Opioids Drugs Product Benchmarking

    • Table Egalet - Company Business Overview

    • Figure Egalet Total Revenue from 2018 to 2020

    • Table Egalet Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Egalet Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Egalet

    • Table Opioids Drugs Product Benchmarking

    • Table Hikma - Company Business Overview

    • Figure Hikma Total Revenue from 2018 to 2020

    • Table Hikma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Hikma Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Hikma

    • Table Opioids Drugs Product Benchmarking

    • Table Endo - Company Business Overview

    • Figure Endo Total Revenue from 2018 to 2020

    • Table Endo Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Endo Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Endo

    • Table Opioids Drugs Product Benchmarking

    • Table Mylan - Company Business Overview

    • Figure Mylan Total Revenue from 2018 to 2020

    • Table Mylan Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Mylan Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Opioids Drugs Product Benchmarking

    • Table Mallinckrodt - Company Business Overview

    • Figure Mallinckrodt Total Revenue from 2018 to 2020

    • Table Mallinckrodt Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Mallinckrodt Sales and Growth Rate Analysis of Opioids Drugs

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Opioids Drugs Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Opioids Drugs Market Revenue by Types (Historical)

    • Table Global Opioids Drugs Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Oxycodone 2016-2021

    • Figure Global Revenue and Growth Rate of Hydromorphone 2016-2021

    • Figure Global Revenue and Growth Rate of Codeine 2016-2021

    • Figure Global Revenue and Growth Rate of Fentanyl 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Opioids Drugs Market Sales by Types (Historical)

    • Table Global Opioids Drugs Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Oxycodone 2016-2021

    • Figure Global Sales and Growth Rate of Hydromorphone 2016-2021

    • Figure Global Sales and Growth Rate of Codeine 2016-2021

    • Figure Global Sales and Growth Rate of Fentanyl 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Opioids Drugs Market Revenue by Types (Forecast)

    • Table Global Opioids Drugs Market Revenue Market Share by Types (Forecast)

    • Table Global Opioids Drugs Market Sales by Types (Forecast)

    • Table Global Opioids Drugs Market Sales Market Share by Types (Forecast)

    • Figure Global Opioids Drugs Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Opioids Drugs

    • Table Global Opioids Drugs Market Revenue by Application (Historical)

    • Table Global Opioids Drugs Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Pain Relief 2016-2021

    • Figure Global Revenue and Growth Rate of Anesthesia 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Opioids Drugs Market Sales by Application (Historical)

    • Table Global Opioids Drugs Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Pain Relief 2016-2021

    • Figure Global Sales and Growth Rate of Anesthesia 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Opioids Drugs Market Revenue by Application (Forecast)

    • Table Global Opioids Drugs Market Revenue Market Share by Application (Forecast)

    • Table Global Opioids Drugs Market Sales by Application (Forecast)

    • Table Global Opioids Drugs Market Sales Market Share by Application (Forecast)

    • Table Global Opioids Drugs Market Revenue by Geography (Historical)

    • Table Global Opioids Drugs Market Revenue Market Share by Geography (Historical)

    • Figure Global Opioids Drugs Revenue Market Share by Geography in 2020

    • Table Global Opioids Drugs Market Sales by Geography (Historical)

    • Table Global Opioids Drugs Market Sales Market Share by Geography (Historical)

    • Figure Global Opioids Drugs Sales Market Share by Geography in 2020

    • Table Global Opioids Drugs Market Revenue by Geography (Forecast)

    • Table Global Opioids Drugs Market Revenue Market Share by Geography (Forecast)

    • Table Global Opioids Drugs Market Sales by Geography (Forecast)

    • Table Global Opioids Drugs Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Opioids Drugs Revenue by Countries from 2016 to 2026

    • Table North America Opioids Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Opioids Drugs Revenue Market Share by Major Countries in 2020

    • Table North America Opioids Drugs Sales by Countries from 2016 to 2026

    • Table North America Opioids Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure North America Opioids Drugs Sales Market Share by Major Countries in 2020

    • Figure USA Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure USA Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table North America Opioids Drugs Sales by Types from 2016 to 2026

    • Table North America Opioids Drugs Sales Market Share by Types from 2016 to 2026

    • Table North America Opioids Drugs Value by Types from 2016 to 2026

    • Table North America Opioids Drugs Value Market Share by Types from 2016 to 2026

    • Table North America Opioids Drugs Sales by Application from 2016 to 2026

    • Table North America Opioids Drugs Sales Market Share by Application from 2016 to 2026

    • Table North America Opioids Drugs Value by Application from 2016 to 2026

    • Table North America Opioids Drugs Value Market Share by Application from 2016 to 2026

    • Table Europe Opioids Drugs Revenue by Countries from 2016 to 2026

    • Table Europe Opioids Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Opioids Drugs Revenue Market Share by Major Countries in 2020

    • Table Europe Opioids Drugs Sales by Countries from 2016 to 2026

    • Table Europe Opioids Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Opioids Drugs Sales Market Share by Major Countries in 2020

    • Figure Germany Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure France Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure France Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Opioids Drugs Sales by Types from 2016 to 2026

    • Table Europe Opioids Drugs Sales Market Share by Types from 2016 to 2026

    • Table Europe Opioids Drugs Value by Types from 2016 to 2026

    • Table Europe Opioids Drugs Value Market Share by Types from 2016 to 2026

    • Table Europe Opioids Drugs Sales by Application from 2016 to 2026

    • Table Europe Opioids Drugs Sales Market Share by Application from 2016 to 2026

    • Table Europe Opioids Drugs Value by Application from 2016 to 2026

    • Table Europe Opioids Drugs Value Market Share by Application from 2016 to 2026

    • Table Asia Opioids Drugs Revenue by Countries from 2016 to 2026

    • Table Asia Opioids Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Opioids Drugs Revenue Market Share by Major Countries in 2020

    • Table Asia Opioids Drugs Sales by Countries from 2016 to 2026

    • Table Asia Opioids Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Opioids Drugs Sales Market Share by Major Countries in 2020

    • Figure China Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure China Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure India Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure India Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Opioids Drugs Sales by Types from 2016 to 2026

    • Table Asia Opioids Drugs Sales Market Share by Types from 2016 to 2026

    • Table Asia Opioids Drugs Value by Types from 2016 to 2026

    • Table Asia Opioids Drugs Value Market Share by Types from 2016 to 2026

    • Table Asia Opioids Drugs Sales by Application from 2016 to 2026

    • Table Asia Opioids Drugs Sales Market Share by Application from 2016 to 2026

    • Table Asia Opioids Drugs Value by Application from 2016 to 2026

    • Table Asia Opioids Drugs Value Market Share by Application from 2016 to 2026

    • Table South America Opioids Drugs Revenue by Countries from 2016 to 2026

    • Table South America Opioids Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Opioids Drugs Revenue Market Share by Major Countries in 2020

    • Table South America Opioids Drugs Sales by Countries from 2016 to 2026

    • Table South America Opioids Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure South America Opioids Drugs Sales Market Share by Major Countries in 2020

    • Figure Brazil Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table South America Opioids Drugs Sales by Types from 2016 to 2026

    • Table South America Opioids Drugs Sales Market Share by Types from 2016 to 2026

    • Table South America Opioids Drugs Value by Types from 2016 to 2026

    • Table South America Opioids Drugs Value Market Share by Types from 2016 to 2026

    • Table South America Opioids Drugs Sales by Application from 2016 to 2026

    • Table South America Opioids Drugs Sales Market Share by Application from 2016 to 2026

    • Table South America Opioids Drugs Value by Application from 2016 to 2026

    • Table South America Opioids Drugs Value Market Share by Application from 2016 to 2026

    • Table Middle East Opioids Drugs Revenue by Countries from 2016 to 2026

    • Table Middle East Opioids Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Opioids Drugs Revenue Market Share by Major Countries in 2020

    • Table Middle East Opioids Drugs Sales by Countries from 2016 to 2026

    • Table Middle East Opioids Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Opioids Drugs Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Opioids Drugs Sales by Types from 2016 to 2026

    • Table Middle East Opioids Drugs Sales Market Share by Types from 2016 to 2026

    • Table Middle East Opioids Drugs Value by Types from 2016 to 2026

    • Table Middle East Opioids Drugs Value Market Share by Types from 2016 to 2026

    • Table Middle East Opioids Drugs Sales by Application from 2016 to 2026

    • Table Middle East Opioids Drugs Sales Market Share by Application from 2016 to 2026

    • Table Middle East Opioids Drugs Value by Application from 2016 to 2026

    • Table Middle East Opioids Drugs Value Market Share by Application from 2016 to 2026

    • Table Africa Opioids Drugs Revenue by Countries from 2016 to 2026

    • Table Africa Opioids Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Opioids Drugs Revenue Market Share by Major Countries in 2020

    • Table Africa Opioids Drugs Sales by Countries from 2016 to 2026

    • Table Africa Opioids Drugs Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Opioids Drugs Sales Market Share by Major Countries in 2020

    • Figure Nigeria Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Opioids Drugs Sales by Types from 2016 to 2026

    • Table Africa Opioids Drugs Sales Market Share by Types from 2016 to 2026

    • Table Africa Opioids Drugs Value by Types from 2016 to 2026

    • Table Africa Opioids Drugs Value Market Share by Types from 2016 to 2026

    • Table Africa Opioids Drugs Sales by Application from 2016 to 2026

    • Table Africa Opioids Drugs Sales Market Share by Application from 2016 to 2026

    • Table Africa Opioids Drugs Value by Application from 2016 to 2026

    • Table Africa Opioids Drugs Value Market Share by Application from 2016 to 2026

    • Table Oceania Opioids Drugs Revenue by Countries from 2016 to 2026

    • Table Oceania Opioids Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Opioids Drugs Revenue Market Share by Major Countries in 2020

    • Table Oceania Opioids Drugs Sales by Countries from 2016 to 2026

    • Table Oceania Opioids Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Opioids Drugs Sales Market Share by Major Countries in 2020

    • Figure Australia Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioids Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Opioids Drugs Sales by Types from 2016 to 2026

    • Table Oceania Opioids Drugs Sales Market Share by Types from 2016 to 2026

    • Table Oceania Opioids Drugs Value by Types from 2016 to 2026

    • Table Oceania Opioids Drugs Value Market Share by Types from 2016 to 2026

    • Table Oceania Opioids Drugs Sales by Application from 2016 to 2026

    • Table Oceania Opioids Drugs Sales Market Share by Application from 2016 to 2026

    • Table Oceania Opioids Drugs Value by Application from 2016 to 2026

    • Table Oceania Opioids Drugs Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Opioids Drugs

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Opioids Drugs with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US